Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2007
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists
Clementina Manera, Maria Grazia Cascio, Veronica Benetti, et al.
Bioorganic & Medicinal Chemistry
|
October 29, 2017
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor
Simone Bertini, Andrea Chicca, Francesca Gado, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 10, 2015
Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor
Giuseppe Saccomanni, Giancarlo Pascali, Sara Del Carlo, et al.
Nutrition and Cancer
|
June 9, 2016
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells
Stefano Fogli, Chiara Arena, Sara Carpi, et al.
Journal of Medicinal Chemistry
|
May 14, 2009
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists
Clementina Manera, Giuseppe Saccomanni, Barbara Adinolfi, et al.
Frontiers in Chemistry
|
October 14, 2022
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB<sub>2</sub>R)
Rebecca Ferrisi, Francesca Gado, Beatrice Polini, et al.
European Journal of Medicinal Chemistry
|
December 9, 2014
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands
Simone Bertini, Teija Parkkari, Juha R Savinainen, et al.
European Journal of Medicinal Chemistry
|
April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold
Clementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
Francesca Gado, Rebecca Ferrisi, Sarah Di Somma, et al.
International Journal of Molecular Sciences
|
February 11, 2023
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
Rebecca Ferrisi, Beatrice Polini, Caterina Ricardi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2007
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists
Clementina Manera, Maria Grazia Cascio, Veronica Benetti, et al.
Bioorganic & Medicinal Chemistry
|
October 29, 2017
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor
Simone Bertini, Andrea Chicca, Francesca Gado, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 10, 2015
Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor
Giuseppe Saccomanni, Giancarlo Pascali, Sara Del Carlo, et al.
Nutrition and Cancer
|
June 9, 2016
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells
Stefano Fogli, Chiara Arena, Sara Carpi, et al.
Journal of Medicinal Chemistry
|
May 14, 2009
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists
Clementina Manera, Giuseppe Saccomanni, Barbara Adinolfi, et al.
Frontiers in Chemistry
|
October 14, 2022
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB<sub>2</sub>R)
Rebecca Ferrisi, Francesca Gado, Beatrice Polini, et al.
European Journal of Medicinal Chemistry
|
December 9, 2014
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands
Simone Bertini, Teija Parkkari, Juha R Savinainen, et al.
European Journal of Medicinal Chemistry
|
April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold
Clementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
Francesca Gado, Rebecca Ferrisi, Sarah Di Somma, et al.
International Journal of Molecular Sciences
|
February 11, 2023
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
Rebecca Ferrisi, Beatrice Polini, Caterina Ricardi, et al.
Page
of 5